Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients
Author(s) -
Xianhui Qin,
Youbao Li,
Ningling Sun,
Wang Hong,
Yan Zhang,
JiGuang Wang,
Jianping Li,
Xin Xu,
Min Liang,
Jing Nie,
Binyan Wang,
Xiaoshu Cheng,
Nanfang Li,
Yingxian Sun,
Lianyou Zhao,
Xiaobin Wang,
Fan Fan Hou,
Yong Huo
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.116.308515
Subject(s) - homocysteine , angiotensin converting enzyme , pharmacology , medicine , enzyme , endocrinology , chemistry , blood pressure , biochemistry
We aimed to examine whether baseline homocysteine (Hcy) concentrations affect antihypertensive responses to enalapril treatment among previously untreated hypertensive patients (n=10 783) in the CSPPT (China Stroke Primary Prevention Trial).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom